A healthcare IT company has acquired a disease management platform to expand into the mobile health sector.
Medivo, which provides support services to patients and physician practices, acquired New Jersey-based WellApps for an undisclosed amount. WellApps’ GI Monitor helps users log and track their symptoms and provide that data to their physicians. It also helps patients with inflammatory bowel disease, Crohn’s disease and ulcerative colitis see correlations between symptoms, meals and medications. The company also has a colonoscopy prep assistant app.
Brett Shamosh co-founded WellApps in 2009 after he suffered a flare-up of ulcerative colitis and needed a way to track his symptoms to give his doctor the most accurate information. Finding nothing fitting that description, he developed a platform himself. Paolo Teodorani and Dr. Edward Shin are also co-founders of the company.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
As part of the deal, Shamosh joins Medivo as a vice president for product development.
Medivo CEO Sundeep Bhan said WellApps complements his company’s growth strategy and plugs it in to the mobile health sector. “This acquisition will increase our ability to address a broader set of medical conditions, which will have a positive impact on our patients and physicians,” Bhan said in a company statement.
Last year, Medivo raised $7 million in a series A financing round led by Safeguard Scientifics (NYSE:SFE) to support product development and expansion of sales and marketing. Medivo’s online platform connects patients to a nationwide network of physicians, lab service centers and home testing services.
